Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.
[Influence of manganese exposure via intracerebral injection on behavioristics and substantia nigra dopaminergic neurons in rats].
MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease.
Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.
Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis.
Adult anaplastic pilocytic astrocytoma - a diagnostic challenge? A case series and literature review.
Dietary salt intake and time to relapse in paediatric multiple sclerosis.
Fatigue Level is Associated with Sleep Quality but not Vector Magnitude in Multiple Sclerosis: 2564 Board #87 June 3, 9: 30 AM - 11: 00 AM.
Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study.
Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.
Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.
KIR4.1: K(+) Channel Illusion or Reality in the Autoimmune Pathogenesis of Multiple Sclerosis.
Prazosin: Order Minipress Mastercard Fedex
IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation.
Critical Appraisal of Evidence for Improving Gait Speed in People with Multiple Sclerosis: Dalfampridine Versus Gait Training.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
Exercise and Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.
Sphingosine-1-phosphate modulators in inflammatory skin diseases-Lining up for clinical translation.
ZFAT gene variant association with multiple sclerosis in the Arabian Gulf population: A genetic basis for gender-associated susceptibility.
Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G.
Hemiplegic Migraine Presenting with Prolonged Somnolence: A Case Report.
MARK2 Rescues Nogo-66-Induced Inhibition of Neurite Outgrowth via Regulating Microtubule-Associated Proteins in Neurons In Vitro.
TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.
Sudden hearing loss as the initial symptom in Japanese patients with multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Pages
« first
‹ previous
…
847
848
849
850
851
852
853
854
855
…
next ›
last »